BHC Bausch Health Companies Inc
Price (delayed)
$6.11
Market cap
$2.25B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.13
Enterprise value
$22.66B
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of
Highlights
The net income has soared by 92% YoY and by 74% from the previous quarter
BHC's EPS has surged by 92% year-on-year and by 72% since the previous quarter
Bausch Health Companies's quick ratio has decreased by 29% YoY and by 22% from the previous quarter
The company's equity fell by 25% YoY and by 9% QoQ
Key stats
What are the main financial stats of BHC
Market
Valuations
Earnings
Shares outstanding
367.93M
Market cap
$2.25B
Enterprise value
$22.66B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.23
EV/EBIT
14.33
EV/EBITDA
7.96
EV/Sales
2.35
Revenue
$9.63B
Gross profit
$6.84B
Operating income
$1.55B
Net income
-$46M
EBIT
$1.58B
EBITDA
$2.85B
Free cash flow
$1.26B
Per share
Balance sheet
Liquidity
EPS
-$0.13
EPS diluted
-$0.13
Free cash flow per share
$3.42
Book value per share
-$3.48
Revenue per share
$26.15
TBVPS
$26.86
Total assets
$26.52B
Total liabilities
$26.85B
Debt
$21.62B
Equity
-$1.28B
Working capital
-$978M
Debt to equity
-16.9
Current ratio
0.86
Quick ratio
0.49
Net debt/EBITDA
7.17
Margins
Efficiency
Dividend
EBITDA margin
29.6%
Gross margin
71.1%
Net margin
-0.5%
Operating margin
16.1%
Return on assets
-0.2%
Return on equity
N/A
Return on invested capital
6.2%
Return on capital employed
8%
Return on sales
16.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BHC stock price
How has the Bausch Health Companies stock price performed over time
Intraday
-2.24%
1 week
-10.28%
1 month
-17.88%
1 year
-40.1%
YTD
-24.19%
QTD
-5.56%
Financial performance
How have Bausch Health Companies's revenue and profit performed over time
Revenue
$9.63B
Gross profit
$6.84B
Operating income
$1.55B
Net income
-$46M
Gross margin
71.1%
Net margin
-0.5%
The net margin has surged by 93% year-on-year and by 74% since the previous quarter
The net income has soared by 92% YoY and by 74% from the previous quarter
The company's operating income has surged by 61% YoY and by 15% QoQ
The operating margin has grown by 46% YoY and by 13% from the previous quarter
Growth
What is Bausch Health Companies's growth rate over time
Valuation
What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.23
EV/EBIT
14.33
EV/EBITDA
7.96
EV/Sales
2.35
BHC's EPS has surged by 92% year-on-year and by 72% since the previous quarter
The company's equity fell by 25% YoY and by 9% QoQ
The price to sales (P/S) is 60% lower than the 5-year quarterly average of 0.6 and 20% lower than the last 4 quarters average of 0.3
The revenue has increased by 10% year-on-year
Efficiency
How efficient is Bausch Health Companies business performance
The ROA has soared by 91% YoY and by 71% from the previous quarter
BHC's return on invested capital has surged by 68% year-on-year and by 17% since the previous quarter
BHC's return on sales has surged by 50% year-on-year and by 11% since the previous quarter
Dividends
What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BHC.
Financial health
How did Bausch Health Companies financials performed over time
The current ratio has contracted by 34% YoY and by 28% from the previous quarter
Bausch Health Companies's quick ratio has decreased by 29% YoY and by 22% from the previous quarter
The company's equity fell by 25% YoY and by 9% QoQ
The debt to equity is up by 23% year-on-year and by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.